Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Corebridge Financial Inc.

Corebridge Financial Inc. cut its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 2.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 145,058 shares of the company’s stock after selling 3,046 shares during the period. Corebridge Financial Inc.’s holdings in Doximity were worth $7,745,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DOCS. Thrivent Financial for Lutherans raised its stake in shares of Doximity by 5.0% in the third quarter. Thrivent Financial for Lutherans now owns 30,991 shares of the company’s stock valued at $1,350,000 after acquiring an additional 1,474 shares in the last quarter. Commerce Bank purchased a new stake in Doximity during the 3rd quarter worth about $314,000. Charles Schwab Investment Management Inc. raised its position in Doximity by 4.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company’s stock valued at $32,808,000 after purchasing an additional 31,966 shares in the last quarter. Cerity Partners LLC boosted its stake in shares of Doximity by 21.4% in the 3rd quarter. Cerity Partners LLC now owns 49,876 shares of the company’s stock valued at $2,173,000 after buying an additional 8,781 shares during the period. Finally, FMR LLC boosted its stake in shares of Doximity by 30.5% in the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after buying an additional 1,598,602 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Insider Activity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 37.40% of the company’s stock.

Doximity Price Performance

DOCS stock opened at $60.59 on Friday. The company has a market cap of $11.31 billion, a price-to-earnings ratio of 60.59, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. The company has a fifty day moving average price of $65.39 and a 200 day moving average price of $54.15. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21.

Analyst Upgrades and Downgrades

DOCS has been the topic of a number of recent research reports. Raymond James restated an “outperform” rating and set a $83.00 target price (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. KeyCorp reduced their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a report on Wednesday, January 8th. Wells Fargo & Company reiterated an “equal weight” rating on shares of Doximity in a research note on Friday, February 7th. Stephens initiated coverage on Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price target on the stock. Finally, Mizuho lifted their price target on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.